These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14150884)

  • 21. Some biochemical changes occurring in muscular dystrophy and their possible genetical significance.
    Monckton G; Nihei T
    Ann N Y Acad Sci; 1966 Sep; 138(1):329-41. PubMed ID: 5230213
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
    Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
    [No Abstract]   [Full Text] [Related]  

  • 23. [ADOLASE ACTIVITY IN A MYOPATHY IN A CHILD].
    GORBACHEVA FE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():958-60. PubMed ID: 14103865
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum enzyme activities in progressive muscular dystrophy].
    Yano I; Furukawa Y; Masaki H; Tani J
    Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
    [No Abstract]   [Full Text] [Related]  

  • 26. [Muscular dystrophy and its problems].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294
    [No Abstract]   [Full Text] [Related]  

  • 27. [Differentiation and dedifferentiation of muscular dystrophy].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Oct; 26(10):2423-42. PubMed ID: 5752013
    [No Abstract]   [Full Text] [Related]  

  • 28. [STUDIES ON SERUM ENZYMES IN CHILDREN WITH PROGRESSIVE MUSCULAR DYSTROPHY].
    GRINIO LP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():961-6. PubMed ID: 14103866
    [No Abstract]   [Full Text] [Related]  

  • 29. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 30. Coenzyme O in Duchenne muscular dystrophy. A preliminary therapeutic trial.
    Sövik O; Strömme JH; Folkers K
    Acta Paediatr Scand; 1971 Jul; 60(4):428-32. PubMed ID: 5556384
    [No Abstract]   [Full Text] [Related]  

  • 31. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma level of hemopexin (Hpx) in families with progressive muscular dystrophy (PMD)].
    Diotallevi P; Balducci E; Canapa A; Danni M; Giamagli CA; Lucesoli S; Ravaglia P; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):531-8. PubMed ID: 3190906
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contribution on the study of pseudohypertrophic muscular dystrophies. I. Benign pseudohypertrophic muscular dystrophy].
    Radu H; Stenzel K
    Dtsch Z Nervenheilkd; 1969; 196(2):92-115. PubMed ID: 5800957
    [No Abstract]   [Full Text] [Related]  

  • 34. The comparative utility of serum creatine kinase versus serum aldolase in the evaluation of muscle disorders.
    Giesker D; Bowers GN
    Conn Med; 1979 Nov; 43(11):699-704. PubMed ID: 389542
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 36. [PROGRESSIVE MUSCULAR DYSTROPHY. VI. INCIDENCE, CLINICAL ASPECTS AND GENETICS OF THE DUCHENNE TYPE].
    MOSER H; WIESMANN U; RICHTERICH R; ROSSI E
    Schweiz Med Wochenschr; 1964 Nov; 94():1610-21. PubMed ID: 14317825
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of the enzyme activity of muscle tissue of normal children and children with progressive muscular dystrophy at different stages of the disease].
    Hooft C; De Laey P; Lambert Y
    Rev Fr Etud Clin Biol; 1966 May; 11(5):510-1. PubMed ID: 5938397
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of the increase of aldolase in blood in muscular dystrophy].
    GENTILI C
    Clin Pediatr (Bologna); 1959 Sep; 41():736-9. PubMed ID: 13827330
    [No Abstract]   [Full Text] [Related]  

  • 39. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 40. [On Becker's benign muscular dystrophy: study of a family with 10 affected members in 6 generations].
    Caruso G; Campanella G
    Acta Neurol (Napoli); 1968; 23(4):709-31. PubMed ID: 5747395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.